Last Updated: May 06, 2024
xenon-pharma.com has 4 NS records, 1 A records, 0 AAAA records, 1 MX records, and 9 TXT records. Name servers for xenon-pharma.com are ns-1027.awsdns-00.org, ns-815.awsdns-37.net, ns-396.awsdns-49.com, ns-1735.awsdns-24.co.uk. A records for xenon-pharma.com are 52.188.162.20. MX records that process @xenon-pharma.com email are xenonpharma-com01c.mail.protection.outlook.com. We have observed xenon-pharma.com to have 4 subdomains. A subdomain count of 4 is considered a small digital footprint. Technology that may be in use at xenon-pharma.com includes atlassian, google. As of May 06, 2024, xenon-pharma.com does not have any threat intelligence reports of concern.
Search DigitalStakeout Footprint to find another asset.
52.188.162.20
No DNS AAAA records
xenonpharma-com01c.mail.protection.outlook.com
ns-1027.awsdns-00.org
ns-815.awsdns-37.net
ns-396.awsdns-49.com
ns-1735.awsdns-24.co.uk
xenon-pharma.com. 300 IN TXT "MS=AFA524ABD3CF9E4A281B51DC441FFA514B8914E1"
xenon-pharma.com. 300 IN TXT "bRMu_7O_fHKeBTeCQBPH"
xenon-pharma.com. 300 IN TXT "v=spf1 ip4:216.129.74.124 ip4:104.211.45.60 include:spf.protection.outlook.com -all"
xenon-pharma.com. 300 IN TXT "MS=ms42731188"
xenon-pharma.com. 300 IN TXT "t03jbw7tyxt6d8yv65r08rg4ht4w3dnn"
xenon-pharma.com. 300 IN TXT "l51sw1nqk7w08cgnjcdc9ddyx7mwbr8f"
xenon-pharma.com. 300 IN TXT "atlassian-domain-verification=0mWfAYtqneKdmOjzAKr0GQPJbIv36YYstNoxuc8B0cOcEVh3ALGyMQUYfl3kusR1"
xenon-pharma.com. 300 IN TXT "smartsheet-site-validation=msbSXmcKYNeRfgknmCc4QcPO7lCphNFz"
xenon-pharma.com. 300 IN TXT "google-site-verification=-hnjrjbq5DUBLu2P7lYFmLPXygbahADqiLssB3eaaL4"
xenon-pharma.com has 4 subdomains in our inventory.
No domain meta-data found. Please check back at a later time.
{"message_type": "certificate_update", "data": {"leaf_cert": {"not_after": 1709769599, "signature_algorithm": "sha256, rsa", "extensions": {"subjectKeyIdentifier": "0E:EC:34:3E:BC:16:E9:F1:37:D7:8C:52:CA:34:39:22:D7:80:2C:A2", "authorityKeyIdentifier": "keyid:A5:B4:D6:EB:36:C4:E7:6B:A6:DF:C4:64:0B:01:2A:20:04:B8:66:23\n", "extendedKeyUsage": "TLS Web server authentication, TLS Web client authentication", "subjectAltName": "DNS:xenon-pharma.com, DNS:*.xenon-pharma.com", "crlDistributionPoints": " URI:http://crl3.digicert.com/GeoTrustGlobalTLSRSA4096SHA2562022CA1.crl\nFull Name:\nFull Name:\n URI:http://crl4.digicert.com/GeoTrustGlobalTLSRSA4096SHA2562022CA1.crl", "keyUsage": "Digital Signature, Key Encipherment", "certificatePolicies": "Policy: 2.23.140.1.2.1\n CPS: http://www.digicert.com/CPS", "ctlPoisonByte": true, "authorityInfoAccess": "CA Issuers - URI:http://cacerts.digicert.com/GeoTrustGlobalTLSRSA4096SHA2562022CA1.crt\nOCSP - URI:http://ocsp.digicert.com\n", "basicConstraints": "CA:FALSE"}, "fingerprint": "EC:58:41:97:63:D9:9C:34:CB:6C:5F:C5:C9:6E:8D:66:9F:85:C6:B1", "all_domains": ["*.xenon-pharma.com", "xenon-pharma.com"], "serial_number": "66CAABB1888AACFC1D15A58C38CFD47", "subject": {"C": null, "CN": "*.xenon-pharma.com", "L": null, "O": null, "ST": null, "emailAddress": null, "OU": null, "aggregated": "/CN=*.xenon-pharma.com"}, "not_before": 1677628800, "issuer": {"C": "US", "CN": "GeoTrust Global TLS RSA4096 SHA256 2022 CA1", "L": null, "O": "DigiCert, Inc.", "ST": null, "emailAddress": null, "OU": null, "aggregated": "/C=US/CN=GeoTrust Global TLS RSA4096 SHA256 2022 CA1/O=DigiCert, Inc."}}, "cert_link": "https://oak.ct.letsencrypt.org/2024h1/ct/v1/get-entries?start=26338977&end=26338977", "source": {"url": "https://oak.ct.letsencrypt.org/2024h1/", "name": "Let's Encrypt 'Oak2024H1' log"}, "update_type": "PrecertLogEntry", "seen": 1677670588.852621, "cert_index": 26338977}}